![](/img/cover-not-exists.png)
Editorial Comment on: Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis
Aristotle BamiasVolume:
55
Year:
2009
Language:
english
DOI:
10.1016/j.eururo.2008.10.022
File:
PDF, 78 KB
english, 2009